Summarized by Daily Strand AI from peer-reviewed source
To understand human pain, scientists need to study the actual nerve cells responsible for feeling it. These nerves bundle together in structures called dorsal root ganglions, or DRGs, which act as gateways for pain signals travelling to the brain. While researchers can sometimes acquire this tissue from organ donors, the cells degrade rapidly. The intense rush to get fresh tissue from a donor to a laboratory has been a major logistical hurdle, restricting this vital research to a few specialized facilities.
Now, researchers have developed a simple preservation method that buys scientists precious time. They tested a specialized nutrient liquid called Hibernate A to store and transport these delicate human tissues. The team found that storing whole DRGs in this liquid for up to sixteen hours yielded the exact same amount of healthy nerve and immune cells as tissue that was processed immediately.
Even better, researchers found they could separate the nerve cells first and store them in the liquid for up to forty-two hours, allowing them to be shipped to geographically distant laboratories. Once they arrived, these shipped nerves still behaved normally. They fired healthy electrical signals and reacted exactly as expected when exposed to capsaicin, the chemical that gives chili peppers their heat. However, readers should keep in mind that this is an early laboratory protocol, and the research abstract does not specify exactly how many organ donors or tissue samples were evaluated.
This might sound like a simple shipping upgrade, but it solves a massive bottleneck in pain research. Historically, scientists have relied heavily on animal models to study pain, but animal nerves often do not react exactly the same way human nerves do. By extending the viability window of human pain receptors to nearly two days, this method allows labs anywhere in the country to conduct experiments on actual human tissue, rather than just those located adjacent to major transplant centers.
Unlocking broader access to human pain nerves could rapidly accelerate the development of new treatments. Chronic pain affects millions of people worldwide, and there is a desperate need for safer, non-addictive alternatives to opioids. Allowing more scientific minds to test new drugs directly on functional human pain receptors is a crucial step toward bringing better, safer medicines to the patients who need them most.
Interested in Neurotech?
Newsletter
Never miss a breakthrough.
Join 10,000+ curious minds getting biotech stories distilled into plain language. Free, three times a week.